Research

Radiation Oncology Division at the Segal Cancer Centre, Jewish General Hospital possesses state of the art equipment for highly targeted radiation therapy with intensity-modulated radio-therapy (IMRT) and stereotactic body radiation therapy (SBRT) using Rapid ArcTM and cone beam CT (CBCT) technology for daily image guidance of treatments. During expansion in 2008, a Brachytherapy suite was integrated within Division with an integrated CT-simulator, representing a unique image guided brachytherapy (IGBT) suite in Canada. This exclusive imaging modality has allowed for significantly improved and convenient brachytherapy procedures to our patients. Furthermore, the existence of this unique imaging modality within brachytherapy suite enabled us to initiate both in-house and phase I/II local, national and international radiation radiotherapy trials in the most conformal form of the contemporary radiotherapy.

The Jewish General Hospital Radiation Oncology Division is one of the few centres in Canada and is unique in Quebec that has a translational science laboratory within its facility. This lab is dedicated to radio-biology, molecular biology and tumour biology basic science research and permits direct links from bench to the clinic.

Our research unit comprises of six clinical research associates that are actively involved within our in-house, provincial, national and international phase I/II/III Radiation studies.

Medical Physics group within our Division is involved in developing translation of fundamental studies in dosimetry and imaging into daily clinical practice. Medical Physics Group represents one of the reference centers for radiochromic film dosimetry that provides consulting for not only users but also PhD and MSc students from all over the world. Physicists are also actively involved in development of the image guidance procedures, which allows highly targeted mode of radiation treatment to be accurately delivered to patients on daily basis through both IGRT and IGBT.

On November 20, 2016, DECOUVERTE, the popular, high-calibre science program on Radio-Canada, showcased ground-breaking research at the Jewish General Hospital.
" Les bactéries à l’assaut du cancer" is a 20 minute report featuring Dr. Gerald Batist, Directror of the JGH Segal Cancer Cenrre, Dr. Té Vuong, JGH Chief of Radio-Oncology, and our partner from Ecole Polytechnique, Dr. Sylvain Martel, who holds the Canadian Research Chair in Medical NanoRobotics.

Page last updated on 

We always seek feedback to make our site better.